Industry stakeholders are steadily expanding their existing capabilities in order to enhance their respective product portfolios and maintain a competitive edge in this steadily evolving market. The companies considered in this analysis have been divided into relevant peer groups (based on company size) and scored on the basis of various parameters, such as types of RTU containers, types of fabrication materials used for containers, types of RTU closures, types of fabrication materials used for closures, number of sterilization techniques used and compatible drug classes.
To Request for Sample report – https://www.rootsanalysis.com/reports/224/request-sample.html
Large players that have received high scores, as per our proprietary scoring criteria, include (arranged in decreasing order of competitiveness score) West Pharmaceutical Services, Stevanato Group, Daikyo Seiko and SCHOTT KAISHA. Amongst these players, West Pharmaceutical Services claims to be engaged in the manufacturing of 24 pre-sterilized / RTU closures (for vials and syringes) using different types of fabrication materials, such as rubber, plastic and metal. It is worth mentioning that most of the pre-sterilized / RTU primary packaging systems manufactured by the company are compatible with biologics, as well as small molecules. Further, Stevanato Group emerged as another prominent player, engaged in the manufacturing of 14 pre-sterilized / RTU primary packaging systems; further, it uses different techniques, such as (in alphabetical order) electron beam, ethylene oxide and steam, for sterilization of its products.
To Request for customize report – https://www.rootsanalysis.com/reports/view_document/pre-sterilized-ready-to-use-primary-packaging-market/224.html#overview
Moreover, Gerresheimer and Sartorius emerged as other prominent players, in terms of relative supplier strength, having an experience of 157 years and 151 years, respectively in the industry. It is worth highlighting that Gerresheimer is currently developing three pre-sterilized / RTU containers, which can be sterilized by both gamma-irradiation and steam.
During the period 2015-2020, more than 45 partnerships were established by stakeholders engaged in this domain. In the given time period, the maximum number of deals were recorded in 2020, followed by those inked in 2017.
Majority of the agreements focused on pre-sterilized / RTU primary packaging components were acquisitions (30%), followed by product / technology integration agreements (24%). Recent examples include (in reverse chronological order) acquisition of GCL Pharma by Bormioli Pharma (2020), Muller + Muller by DWK Life Sciences (2020), CSP Technologies by Aptar Pharma (2018), and Triveni Polymer by Gerresheimer (2018). Interestingly, industry players based in Europe were involved in majority of the intercontinental and intracontinental partnership agreements.
For additional details, To request for report, click under – https://www.rootsanalysis.com/reports/224/request-sample.html
You may also be interested in the following titles:
- Progressive Supranuclear Palsy: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030
- Soft Tissue Sarcoma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030
- Polycystic Ovarian Syndrome (PCOS): Pipeline Review, Developer Landscape and Competitive Insights, 2021-2030
+1 (415) 800 3415